Loading…

Functional hearing impairment common in Parkinson’s disease: Insights from a pilot study

Hearing impairments in Parkinson’s Disease (PD) have received limited attention in the past, possibly because PD patients often report no perceived hearing disability, yet negative consequences of hearing impairment might aggravate communication difficulties and social withdrawal. Our aim was to inv...

Full description

Saved in:
Bibliographic Details
Published in:Clinical neurology and neurosurgery 2024-11, Vol.246, p.108524, Article 108524
Main Authors: Jose, Miguel, Nene, Devavrat, Choi, Mathilda Won Yong, Yu, Adam C., Small, Jeff, Mirian, Maryam, Jenstad, Lorienne, Appel-Cresswell, Silke
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hearing impairments in Parkinson’s Disease (PD) have received limited attention in the past, possibly because PD patients often report no perceived hearing disability, yet negative consequences of hearing impairment might aggravate communication difficulties and social withdrawal. Our aim was to investigate functional hearing (speech in noise recognition) in PD and evaluate its relationship to neuropsychiatric symptoms, cognition and quality of life. Participants with PD were recruited in a tertiary movement disorder clinic. Demographic, audiological, neuropsychiatric and quality of life data were collected. Participants underwent pure tone audiometry (PTA) and Hearing in Noise test (HINT) as a part of their audiological evaluation. A total of 29 participants (mean age: 65.8±8.3 years, M:F= 1.6:1, mean disease duration 5.2 ± 4.0 years) completed the study. All assessments were done in the ON state. 19/29 (65.5 %) participants had normal tone audiometry for age; functional hearing loss, however, was present in 17/29 (58.6 %) according to the HINT. 65 % (11/17) of the affected participants had a disease duration of
ISSN:0303-8467
1872-6968
1872-6968
DOI:10.1016/j.clineuro.2024.108524